Caplin Point Laboratories (BOM:524742) Net Change in Cash : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Caplin Point Laboratories's Net Change in Cash for the three months ended in Mar. 2025 was ₹0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Caplin Point Laboratories Net Change in Cash Historical Data

The historical data trend for Caplin Point Laboratories's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Net Change in Cash Chart

Caplin Point Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Change in Cash

Get a 7-Day Free Trial

2,149.50

-808.10

268.00

-388.60

607.50

Caplin Point Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-	-

Caplin Point Laboratories Net Change in Cash Calculation

Caplin Point Laboratories's Net Change in Cash for the fiscal year that ended in Mar. 2025 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	4323.7	+	-3347.3	+	-383.2	+	14.3
	=	608

Caplin Point Laboratories's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Caplin Point Laboratories's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Net Change in Cash

Comparable Companies

BOM:530019 BOM:543322 BOM:524558 BOM:524816 BOM:532482 BOM:533573 BOM:500126 BOM:544210 BOM:544222 BOM:540596 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.

Caplin Point Laboratories Headlines

No Headlines